Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Headache
|
November 3, 2020
Equity of African American Men in Headache in the United States: A Perspective From African American Headache Medicine Specialists (Part 1)
Larry Charleston, Roderick C Spears, Charles Flippen
Current Pain and Headache Reports
|
March 23, 2021
Carnitine Responsive Migraine Headache Syndrome: Case Report and Review of the Literature
Larry Charleston, Suad Khalil, William B Young
Neurogastroenterology and Motility
|
August 12, 2024
Evidence-based review and frontiers of migraine therapy
Kaitlin A Greene, Amy A Gelfand, Larry Charleston
Headache
|
November 4, 2025
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine study
Jessica Ailani, Larry Charleston, Shannon Strom, et al.
Headache
|
February 16, 2016
An Analysis of UCNS Certified Headache Center Patient Intake Forms
Roni Sharon, Melissa Rayhill, Joseph Viknevich, et al.
Headache
|
June 2, 2025
Perceived discrimination and migraine-specific quality of life: A cross-sectional survey study in a Black/African American sample
Mara Getz, Larry Charleston, Cynthia E Armand, et al.
Headache
|
August 9, 2025
Plain Language Summary Publication: Perceived discrimination and migraine-specific quality of life: A cross-sectional survey study in a Black/African American sample
Mara Getz, Larry Charleston, Cynthia E Armand, et al.
The Journal of Headache and Pain
|
February 8, 2022
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
Richard B Lipton, Larry Charleston, Cristina Tassorelli, et al.
The Journal of Headache and Pain
|
February 22, 2022
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
Dawn C Buse, Paul K Winner, Larry Charleston, et al.
Current Medical Research and Opinion
|
March 30, 2022
Migraine history and response to lasmiditan across racial and ethnic groups
Larry Charleston, Belinda Savage-Edwards, Sonja M Bragg, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Headache
|
November 3, 2020
Equity of African American Men in Headache in the United States: A Perspective From African American Headache Medicine Specialists (Part 1)
Larry Charleston, Roderick C Spears, Charles Flippen
Current Pain and Headache Reports
|
March 23, 2021
Carnitine Responsive Migraine Headache Syndrome: Case Report and Review of the Literature
Larry Charleston, Suad Khalil, William B Young
Neurogastroenterology and Motility
|
August 12, 2024
Evidence-based review and frontiers of migraine therapy
Kaitlin A Greene, Amy A Gelfand, Larry Charleston
Headache
|
November 4, 2025
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine study
Jessica Ailani, Larry Charleston, Shannon Strom, et al.
Headache
|
February 16, 2016
An Analysis of UCNS Certified Headache Center Patient Intake Forms
Roni Sharon, Melissa Rayhill, Joseph Viknevich, et al.
Headache
|
June 2, 2025
Perceived discrimination and migraine-specific quality of life: A cross-sectional survey study in a Black/African American sample
Mara Getz, Larry Charleston, Cynthia E Armand, et al.
Headache
|
August 9, 2025
Plain Language Summary Publication: Perceived discrimination and migraine-specific quality of life: A cross-sectional survey study in a Black/African American sample
Mara Getz, Larry Charleston, Cynthia E Armand, et al.
The Journal of Headache and Pain
|
February 8, 2022
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
Richard B Lipton, Larry Charleston, Cristina Tassorelli, et al.
The Journal of Headache and Pain
|
February 22, 2022
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
Dawn C Buse, Paul K Winner, Larry Charleston, et al.
Current Medical Research and Opinion
|
March 30, 2022
Migraine history and response to lasmiditan across racial and ethnic groups
Larry Charleston, Belinda Savage-Edwards, Sonja M Bragg, et al.
Page
of 5